Cargando…

Case report: Congenital mesoblastic nephroma

INTRODUCTION AND IMPORTANCE: Congenital mesoblastic nephroma is a common benign renal tumor that mainly affects infants below the age of six months (Daskas et al., 2002). Identifying the pathology type is crucial for determining the appropriate plan of action and predicting the patient's progno...

Descripción completa

Detalles Bibliográficos
Autores principales: De Wilde, Kristen, Zuberi, Jamshed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201815/
https://www.ncbi.nlm.nih.gov/pubmed/37141775
http://dx.doi.org/10.1016/j.ijscr.2023.108233
_version_ 1785045331829850112
author De Wilde, Kristen
Zuberi, Jamshed
author_facet De Wilde, Kristen
Zuberi, Jamshed
author_sort De Wilde, Kristen
collection PubMed
description INTRODUCTION AND IMPORTANCE: Congenital mesoblastic nephroma is a common benign renal tumor that mainly affects infants below the age of six months (Daskas et al., 2002). Identifying the pathology type is crucial for determining the appropriate plan of action and predicting the patient's prognosis. CASE PRESENTATION: A one-day-old Hispanic neonate was referred for surgical evaluation after detecting a LUQ mass. Ultrasound imaging revealed a heterogenous solid mass that infiltrated the hilum of the left kidney. The patient underwent a left radical nephrectomy, and the pathology results indicated that the mass was consistent with the classic type of congenital mesoblastic nephroma. The patient will be closely monitored by nephrology with frequent abdominal ultrasounds. CLINICAL DISCUSSION: The case describes a one-day-old female baby with an asymptomatic LUQ abdominal mass, which was diagnosed as mesoblastic nephroma. The baby was born full-term with no significant medical history, and after experiencing hypertensive episodes, she underwent a left radical nephrectomy to remove the tumor. Pathology confirmed mesoblastic nephroma, classic type, and the patient was diagnosed with stage I disease since the tumor was entirely resected with no renal vessel involvement. Follow-up ultrasounds were recommended to monitor for recurrence, and chemotherapy may be considered if recurrence occurs (Pachl et al., 2020). Calcium and renin levels should also be monitored (Bendre et al., 2014). CONCLUSION: Although congenital mesoblastic nephroma is typically benign, patients require ongoing monitoring for potential paraneoplastic syndromes. Furthermore, certain types of mesoblastic nephroma can progress to malignancy, necessitating close follow-up during the first few years of life.
format Online
Article
Text
id pubmed-10201815
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102018152023-05-23 Case report: Congenital mesoblastic nephroma De Wilde, Kristen Zuberi, Jamshed Int J Surg Case Rep Case Report INTRODUCTION AND IMPORTANCE: Congenital mesoblastic nephroma is a common benign renal tumor that mainly affects infants below the age of six months (Daskas et al., 2002). Identifying the pathology type is crucial for determining the appropriate plan of action and predicting the patient's prognosis. CASE PRESENTATION: A one-day-old Hispanic neonate was referred for surgical evaluation after detecting a LUQ mass. Ultrasound imaging revealed a heterogenous solid mass that infiltrated the hilum of the left kidney. The patient underwent a left radical nephrectomy, and the pathology results indicated that the mass was consistent with the classic type of congenital mesoblastic nephroma. The patient will be closely monitored by nephrology with frequent abdominal ultrasounds. CLINICAL DISCUSSION: The case describes a one-day-old female baby with an asymptomatic LUQ abdominal mass, which was diagnosed as mesoblastic nephroma. The baby was born full-term with no significant medical history, and after experiencing hypertensive episodes, she underwent a left radical nephrectomy to remove the tumor. Pathology confirmed mesoblastic nephroma, classic type, and the patient was diagnosed with stage I disease since the tumor was entirely resected with no renal vessel involvement. Follow-up ultrasounds were recommended to monitor for recurrence, and chemotherapy may be considered if recurrence occurs (Pachl et al., 2020). Calcium and renin levels should also be monitored (Bendre et al., 2014). CONCLUSION: Although congenital mesoblastic nephroma is typically benign, patients require ongoing monitoring for potential paraneoplastic syndromes. Furthermore, certain types of mesoblastic nephroma can progress to malignancy, necessitating close follow-up during the first few years of life. Elsevier 2023-04-18 /pmc/articles/PMC10201815/ /pubmed/37141775 http://dx.doi.org/10.1016/j.ijscr.2023.108233 Text en © 2023 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
De Wilde, Kristen
Zuberi, Jamshed
Case report: Congenital mesoblastic nephroma
title Case report: Congenital mesoblastic nephroma
title_full Case report: Congenital mesoblastic nephroma
title_fullStr Case report: Congenital mesoblastic nephroma
title_full_unstemmed Case report: Congenital mesoblastic nephroma
title_short Case report: Congenital mesoblastic nephroma
title_sort case report: congenital mesoblastic nephroma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201815/
https://www.ncbi.nlm.nih.gov/pubmed/37141775
http://dx.doi.org/10.1016/j.ijscr.2023.108233
work_keys_str_mv AT dewildekristen casereportcongenitalmesoblasticnephroma
AT zuberijamshed casereportcongenitalmesoblasticnephroma